Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Mathoulin-Portier

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Anticancer Research|November 20, 2001
PS2 expression in BRCA1-associated breast cancersE Charafe-Jauffre, F Eisinger, M P Mathoulin-Portier, et al.
Annales De Pathologie|February 20, 2002
[Mammary carcinoma arising in microglandular adenosis: a case report]E Charafe-Jauffret, J Jacquemier, B Lelong, et al.
Annales De Pathologie|February 21, 1998
[Juxtacortical chondrosarcoma. A entity to be differentiated from periosteal osteosarcoma]M P Mathoulin-Portier, F Portier, F Penault-Llorca, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 25, 1998
Malignant mullerian mixed tumor of the uterine cervix with adenoid cystic componentM P Mathoulin-Portier, F Penault-Llorca, C Labit-Bouvier, et al.
Oncology Reports|April 18, 2000
Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclinM P Mathoulin-Portier, P Viens, D Cowen, et al.
Annales De Pathologie|September 1, 1996
[Pancreatic and duodenal somatostatinoma. Two clinico-pathologic entities]M P Mathoulin-Portier, M J Payan, G Monges, et al.
Annales De Pathologie|April 4, 1998
[Clear cell sarcoma of the kidney relapsing after 10 years of asymptomatic evolution]E Charafe, F Penault-Llorca, M P Mathoulin-Portier, et al.
International Journal of Cancer|March 17, 2000
Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3J Jacquemier, M P Mathoulin-Portier, R Valtola, et al.
Bone Marrow Transplantation|June 1, 2002
Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantationA C Braud, M P Mathoulin Portier, V J Bardou, et al.
American Journal of Clinical Pathology|November 5, 1999
Differential MUC 1 expression in normal and neoplastic human pancreatic tissue. An immunohistochemical study of 60 samplesG M Monges, M P Mathoulin-Portier, R B Acres, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Anticancer Research|November 20, 2001
PS2 expression in BRCA1-associated breast cancersE Charafe-Jauffre, F Eisinger, M P Mathoulin-Portier, et al.
Annales De Pathologie|February 20, 2002
[Mammary carcinoma arising in microglandular adenosis: a case report]E Charafe-Jauffret, J Jacquemier, B Lelong, et al.
Annales De Pathologie|February 21, 1998
[Juxtacortical chondrosarcoma. A entity to be differentiated from periosteal osteosarcoma]M P Mathoulin-Portier, F Portier, F Penault-Llorca, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 25, 1998
Malignant mullerian mixed tumor of the uterine cervix with adenoid cystic componentM P Mathoulin-Portier, F Penault-Llorca, C Labit-Bouvier, et al.
Oncology Reports|April 18, 2000
Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclinM P Mathoulin-Portier, P Viens, D Cowen, et al.
Annales De Pathologie|September 1, 1996
[Pancreatic and duodenal somatostatinoma. Two clinico-pathologic entities]M P Mathoulin-Portier, M J Payan, G Monges, et al.
Annales De Pathologie|April 4, 1998
[Clear cell sarcoma of the kidney relapsing after 10 years of asymptomatic evolution]E Charafe, F Penault-Llorca, M P Mathoulin-Portier, et al.
International Journal of Cancer|March 17, 2000
Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3J Jacquemier, M P Mathoulin-Portier, R Valtola, et al.
Bone Marrow Transplantation|June 1, 2002
Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantationA C Braud, M P Mathoulin Portier, V J Bardou, et al.
American Journal of Clinical Pathology|November 5, 1999
Differential MUC 1 expression in normal and neoplastic human pancreatic tissue. An immunohistochemical study of 60 samplesG M Monges, M P Mathoulin-Portier, R B Acres, et al.
Pageof 2